Save
Pediatric Thrombosis
ISTH Academy, Char Witmer & Heleen van Ommen, 286682
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study
ISTH Academy, Marcello Di Nisio, 286267
Corrigendum
ISTH Academy, Session Speakers, 286268
Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P‐selectin predict occult cancer after unprovoked venous thromboembolism
ISTH Academy, Fredrik Stangenberg, 286269
Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficiencies
ISTH Academy, Delphine Borgel, 286270
Prevalence of postpartum venous thromboembolism risk factors in an Irish urban obstetric population
ISTH Academy, , 286271
Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients
ISTH Academy, Bhavya Doshi, 286272
Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk
ISTH Academy, , 286273
Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study
ISTH Academy, Borge Nordestgaard, 286274
Quality of life and functional limitations after pulmonary embolism and its prognostic relevance
ISTH Academy, Mareike Lankeit, 286275
What The Neighbors Say
ISTH Academy, Session Speakers, 286276
Mechanisms of vascular permeability and remodeling associated with hemarthrosis in factor VIII‐deficient mice
ISTH Academy, Esther J. Cooke, 286277
Thrombin: Coagulation's master regulator of innate immunity
ISTH Academy, Edward Conway, 286278
Transgender patients and the role of the coagulation clinician
ISTH Academy, Mareike Lankeit, 286279
International Society on Thrombosis and Haemostasis core curriculum project: Core competencies in laboratory thrombosis and hemostasis
ISTH Academy, Karen Moffat, 286280
ISTH News and Updates: Join the ISTH Today
ISTH Academy, Session Speakers, 286281
Glucose metabolism affects coagulation factors: The NEO study
ISTH Academy, Astrid Van Hylckama Vlieg, 286282
Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC
ISTH Academy, Bernard Tardy, 286283
A Genome Wide Association Study on plasma FV levels identified PLXDC2 as a new modifier of the coagulation process
ISTH Academy, Pierre-Emmanuel Morange, 286284
Ischemic limb necrosis in septic shock: What is the role of high‐dose vasopressor therapy?
ISTH Academy, Mareike Lankeit, 286285
Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation
ISTH Academy, Toshiaki Iba, 286286
Issue Information
ISTH Academy, Session Speakers, 286287
The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia
ISTH Academy, Allyson M. Pishko, 286288
Aquagenic pruritus in essential thrombocythemia is associated with a higher risk of thrombosis
ISTH Academy, Christelle Le Gall‐Ianotto, 286289
Defective fibrin deposition and thrombus stability in Bambi mice are mediated by elevated anticoagulant function
ISTH Academy, Isabelle Salles-Crawley, 286290
Temporal map of the pig polytrauma plasma proteome with fluid resuscitation and intravenous vitamin C treatment
ISTH Academy, Ramesh Natarajan, 286291
Purification of silica‐free DNA and characterization of its role in coagulation
ISTH Academy, Paul Kim, 286292
Thrombophilia testing: What can be tested & What should be tested
ISTH Academy, Joost Meijers and Saskia Middeldorp, 273715
Recognizing Excellence in Peer Review
ISTH Academy, Session Speakers, 286318
The risk of arterial thromboembolic events after cancer diagnosis
ISTH Academy, Babak B. Navi, 286319
Platelet preparation for function testing in the laboratory and clinic: Historical and practical aspects
ISTH Academy, Christian Gachet, 286320
Hemostatic complications associated with ventricular assist devices
ISTH Academy, Thomas Deloughery, 286321
Blood platelet research in autism spectrum disorders: In search of biomarkers
ISTH Academy, Kathleen Freson, 286322
Corrigendum
ISTH Academy, Session Speakers, 286323
Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions
ISTH Academy, Mateo Porres‐Aguilar, 286324
Needs and challenges among physicians and researchers in thrombosis and hemostasis: Results from an international study
ISTH Academy, Mateo Porres‐Aguilar, 286325
ISSUE INFORMATION
ISTH Academy, Session Speakers, 286326
Limited factor VIIa surface localization requirement of the factor VIIa–induced overall thrombin generation in platelet‐rich hemophilia A plasma
ISTH Academy, Vincenzo Musolino, 286327
Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome
ISTH Academy, Marie Christine Alessi, 286328
Characterization of a transgenic mouse model of chronic conditional platelet depletion
ISTH Academy, Randall Worth, 286329
Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability
ISTH Academy, Anne Angelillo- Scherrer, 286330
#WomenInMedicine: Progress in gender equity at Research and Practice in Thrombosis and Haemostasis
ISTH Academy, Mary Cushman, 286331
Prolonged APTT of unknown etiology: A systematic evaluation of causes and laboratory resource use in an outpatient hemostasis academic unit
ISTH Academy, Erich De Paula, 286332
Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017
ISTH Academy, Pamela L. Lutsey, 286333
Alternative trafficking of Weibel‐Palade body proteins in CRISPR/Cas9‐engineered von Willebrand factor–deficient blood outgrowth endothelial cells
ISTH Academy, Ruben Bierings, 286334
Corrigendum
ISTH Academy, Session Speakers, 286335
Blood platelets: Circulating mirrors of neurons?
ISTH Academy, Ilaria Canobbio, 286336
Post‐thrombotic syndrome in children: Measurement properties of CAPTSure, a new diagnostic tool
ISTH Academy, Maria Laura Avila, 286337
Erratum
ISTH Academy, Session Speakers, 286338
Factor XII – What's important but not commonly thought about
ISTH Academy, Alvin Schmaier, 286339
Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study
ISTH Academy, Matthew Wanat, 286340
Ruling out lupus anticoagulants with mixing test–specific cutoff assessment and the index of circulating anticoagulant
ISTH Academy, Osamu Kumano, 286341
Low‐dose immune tolerance induction for children with hemophilia A with poor‐risk high‐titer inhibitors: A pilot study in China
ISTH Academy, Runhui Wu, 286342
The experience of postpartum bleeding in women with inherited bleeding disorders
ISTH Academy, Michelle Sholzberg, 286343
Inherited thrombophilia and portal vein thrombosis in cirrhosis: A systematic review and meta‐analysis
ISTH Academy, Jonathan Stine, 286344
Thrombosis and hemostasis health in pregnancy: Registries from the International Society on Thrombosis and Haemostasis
ISTH Academy, Maha Othman, 286345
Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation
ISTH Academy, Oliver Koenigsbruegge, 286346
Plasma levels of mannose‐binding lectin and future risk of venous thromboembolism
ISTH Academy, Robin Amanda Liang, 286243
Managing sepsis‐associated coagulopathy remains an enigma
ISTH Academy, Jecko Thachil, 286244
Hypothermia‐induced activation of the splenic platelet pool as a risk factor for thrombotic disease in a mouse model
ISTH Academy, Hiroki Tanaka, 286245
Topical tranexamic acid inhibits fibrinolysis more effectively when formulated with self‐propelling particles
ISTH Academy, Amedeo Piazza, 286246
Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients
ISTH Academy, Sylvia Haas, 286247
Thromboembolism in major joint prosthetic surgery: False or fact
ISTH Academy, Ola E. Dahl, 286248
Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey
ISTH Academy, Hannah Cohen, 286249
Definitions, adjudication, and reporting of pulmonary embolism–related death in clinical studies: A systematic review
ISTH Academy, Farrukh Awan, 286250
Platelet‐derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice
ISTH Academy, Matthew Neal, 286251
Trauma‐targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model
ISTH Academy, Anirban Sen Gupta, 286252
Heparin‐induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants
ISTH Academy, Uri Pollak, 286253
The role of a specialist bridging service. A New Zealand prospective study of 600 patients
ISTH Academy, Ruell Jackie, 286254
ISTH news and updates: Join the ISTH today
ISTH Academy, Session Speakers, 286255
Toll‐like receptors 2 and 7 mediate coagulation activation and coagulopathy in murine sepsis
ISTH Academy, Wei Chao, 286256
Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variability
ISTH Academy, Virginie Siguret-Depasse, 286257
Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome
ISTH Academy, Anetta Undas, 286258
The potential of serpins for future treatment for haemophilia
ISTH Academy, Josefin Ahnstrom, 286259
What The Neighbors Say
ISTH Academy, Session Speakers, 286260
George J. Broze Jr., MD (3 August 1946–19 June 2019)
ISTH Academy, Session Speakers, 286261
Engineering a protein Z‐dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment
ISTH Academy, Xin Huang, 286262
Issue Information
ISTH Academy, Session Speakers, 286263
Tranexamic acid for trauma: Repackaged and redelivered
ISTH Academy, Keith B. Neeves, 286264
The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH
ISTH Academy, Tzu Fei Wang, 286265
Does the Villalta scale capture the essence of postthrombotic syndrome? A qualitative study of patient experience and expert opinion
ISTH Academy, Hilde Skuterud Wik, 286266
Risk assessment models: thromboprophylaxis & VTE recurrence
ISTH Academy, Lara Roberts and Sabine Eichinger, 273714
Inhibitors in hemophilia: Risk factors, biomarkers and other predictors
ISTH Academy, Samantha Gouw and Rolf Carl Ljung, 273713
Physical proximity and functional cooperation of glycoprotein 130 and glycoprotein VI in platelet membrane lipid rafts
ISTH Academy, Isabelle ODIN, 286214
Mice, men, and differences therein
ISTH Academy, Alisa Wolberg, 286215
Professor Helge Stormorken, 1922‐2019
ISTH Academy, Session Speakers, 286216
Corrigendum
ISTH Academy, Session Speakers, 286217
Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
ISTH Academy, Suzanne Cannegieter, 286218
Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH
ISTH Academy, Gary Moore, 286219
No resistance to activated protein C resistance—but choose wisely
ISTH Academy, Rita Selby, 286220
Response to Letter to the Editor submitted by Dr. Wada and Dr. Yamakawa re: Trauma‐induced coagulopathy: The past, present, and future
ISTH Academy, Session Speakers, 286221
Sex matters: Practice 5P's when treating young women with venous thromboembolism
ISTH Academy, DARIO ZAZZARO, 286222
Genomic momentum for hemostasis and thrombosis
ISTH Academy, Session Speakers, 286230
Erratum
ISTH Academy, Session Speakers, 286231
Issue Information
ISTH Academy, Session Speakers, 286232
Cell surface expression of HLA I molecules as a marker of young platelets
ISTH Academy, Blandine Maître, 286233
Variability of von Willebrand factor‐related parameters in endothelial colony forming cells
ISTH Academy, Jeroen Eikenboom, 286234
Role of RXRβ in platelet function and arterial thrombosis
ISTH Academy, benjamin taisne, 286235
New insights into cytoskeletal remodeling during platelet production
ISTH Academy, Wolfgang Bergmeier, 286236
Trauma‐induced coagulopathy: The past, present, and future: A comment
ISTH Academy, Puja Soni, 286237

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings